Pfizer plans to test a combination of three novel cancer drugs in humans next year, as the US drugmaker seeks to make up lost ground in the race to develop a new generation of “immunotherapy” medicines that turn the body into a weapon against tumours.
辉瑞(Pfizer)计划明年在人体上测试综合使用三种新型抗癌药的疗效。这家美国药企正寻求在研发新一代“免疫疗法”药物的竞赛中收复失地，这类药物能把人体变成对抗肿瘤的武器。
您已阅读14%（336字），剩余86%（2077字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。